Tag: <span>HIV pre-exposure</span>

Home / HIV pre-exposure
Post

New study supports pricing long-acting injectable cabotegravir to compete with generic oral HIV pre-exposure prophylaxis

MASSACHUSETTS GENERAL HOSPITAL BOSTON – The value of a new, highly effective long-acting injectable HIV prevention medication, recently approved by the Food and Drug Administration, will hinge on how it is priced, according to a study led by researchers at Massachusetts General Hospital (MGH) published in Annals of Internal Medicine. The study authors demonstrate that the superiority of long-acting...